Objectives: Vocal fold scarring remains a therapeutic challenge. Previous studies have indicated that hepatocyte growth factor (HGF), a strong antifibrotic element, has therapeutic potential for restoring scarred vocal folds. To enhance the effect of HGF in vivo, we developed a novel drug delivery system (DDS) in which HGF is embedded in gelatin hydrogel and continuously released over a period of 2 weeks. In the present study we investigated the therapeutic efficacy of the HGF DDS on vocal fold scarring by using a canine model.
INTRODUCTION
Vocal fold scarring may occur after injury or inflammation. Scarring disrupts the layered structure of the lamina propria, thus changing the viscoelasticity of the vocal fold mucosa and often resulting in severe and intractable dysphonia. Although various injectable materials such as bovine autologous or homologous collagen and autologous fat have been used in an attempt to soften scarred vocal folds, [1] [2] [3] [4] it is difficult to restore vocal fold scars to a normal state.
Previous histologic studies have revealed dense and/or disorganized collagen deposition, decreased elastin, and occasional decreases of hyaluronic acid (HA) in the lamina propria of scarred vocal folds. 5 Hyaluronic acid is thought to play a major role in maintaining the viscoelasticity of the lamina pro-pria in the vocal fold, and is believed to be closely associated with scarless wound healing. 6, 7 Thus, a material that increases HA production and reduces collagen synthesis from fibroblasts in the vocal fold lamina propria might be useful in treating vocal fold scarring.
Hepatocyte growth factor (HGF) has strong antifibrotic activity, and has been proven to contribute to the prevention or complete resolution of fibrosis in the liver, kidney, and lung in animal models. 8 It has also been found to have some therapeutic potential in restoring scarred vocal folds in animal models. [9] [10] [11] However, the biological activity of HGF may be limited in vivo because of rapid disposal by diffusion. 12 Hirano et al 11 attempted to treat scarred vocal folds in a canine model by local administration of HGF solution. Although encouraging results were noted with regard to vibratory function and some histologic aspects, the effects were limited by the extensive individual variation in mucosal wave patterns. Histologic examinations indicated a resolution of excessive collagen deposition and tissue contraction, but there was no improvement in the loss of elastin. These results warranted examination of this strategy for better regeneration of vocal folds.
A biodegradable hydrogel has been developed to enhance the in vivo regenerative effects of growth factors such as HGF, basic fibroblast growth factor, platelet-derived growth factor, and epidermal growth factor, and has been successful in the controlled release of biologically active growth factors in other parts of the body. [12] [13] [14] [15] [16] [17] [18] In the present study, we employed a hydrogel drug delivery system (DDS) with HGF to enhance the regenerative effects of HGF for treatment of vocal fold scarring. In this system, HGF was embedded in gelatin hydrogel and gradually released in a continuous fashion over a 2-week period in vivo. In the current study we aimed to investigate the therapeutic efficacy of the HGF DDS on vocal fold scarring using a canine model.
MATERIALS AND METHODS
Animals. Eight beagles weighing 10 to 12 kg were used in this study. All experimental protocols were approved by the Animal Research Committee of the Graduate School of Medicine, Kyoto University. Animal care was provided under the supervision of the Institute of Laboratory Animals of the Graduate School of Medicine, Kyoto University.
Preparation of HGF Hydrogel. Human recombinant HGF (lot 0203S201-A) was obtained from PeproTech EC, Ltd, London, England. Biodegradable hydrogels were developed by the Department of Biomaterials, Field of Tissue Engineering, Institute for Frontier Medical Sciences, Kyoto University. 12, 13 Briefly, the hydrogel was constituted by chemical cross-linking of acidic gelatin with glutaraldehyde. Fifty milliliters of acidic gelatin aqueous solution (5% wt/wt) was mixed with 50 μL of glutaraldehyde aqueous solution (25% wt/wt) to give a final concentration of 6.25 mmol/L. The water content of the hydrogel was 94.8%. Next, 1 μg of HGF solution in 20 μL of phosphate-buffered saline solution (PBS) was dripped onto the gelatin hydrogels and left overnight at 4°C to create HGF hydrogel. It has been confirmed that once the HGF hydrogel is administered in vivo, HGF is gradually and continuously released at the site over a 2-week period. 12 Surgical Procedure. All animals were sedated under general anesthesia with intramuscular injections of ketamine hydrochloride (15 mg/kg) and xylazine hydrochloride (6 mg/kg). A direct laryngoscope was inserted into the larynx to visualize the glottis. The vocal folds were unilaterally scarred by stripping the entire layer of the lamina propria down to the muscle, and the contralateral vocal folds were kept intact to use as normal controls. The sides used for scarring were randomly selected.
At 1 month after the procedure, 0.5 mL of hydrogel solution containing 1 μg of HGF was injected into the scarred vocal folds of 4 dogs (HGF-treated group) with a transoral intracordal injector, and 0.5 mL of hydrogel solution containing 1 μg of PBS was injected into the scarred folds of the other 4 dogs (sham group). All animals were euthanized 6 months after surgery by intracardiac injection of pentobarbital sodium. Whole larynges were harvested and used for excised larynx experiments to examine vibratory function, and then were subjected to histologic examination after the excised larynx experiments.
Vibratory Examination With Excised Larynx Setup. Vocal fold vibration was examined with an excised larynx setup. To better visualize the vocal folds, we removed supraglottic structures such as the epiglottis, false vocal folds, and aryepiglottic folds after resection of the superior portion of the thyroid cartilage. The arytenoid adduction procedure was bilaterally performed with 3-0 nylon suture used to close the glottis. The larynx was mounted on a table, and an endotracheal tube was inserted into the trachea and tightly clamped. Airflow was directed through the tube to generate vocal fold vibrations. During the vibratory examination, saline solution was dripped onto the vocal folds to prevent dehydration. A high-speed digital imaging system (Memrecam, NAC Image Technology, Osaka, Japan) was used to record vocal fold vibrations from the superior view. The camera was mounted 50 cm above the larynx, and the image was viewed on a monitor. The images were recorded at a frame rate of 1,000 frames per second, and the amplitude of the mucosal wave and the glottal gap were compared for the HGF-treated and the sham groups. The amplitude of the mucosal wave and the glottal gap were measured with image analysis software (Scion Image beta3b, Frederick, Maryland). The distance (d1) from the midline of the glottis to the free edge of the vocal fold was measured at the anteroposterior middle portion of the vocal fold during the closed phase, and then the same distance (d2) was measured at the maximum open phase. The mucosal wave amplitude was defined by subtracting d1 from d2, and was normalized by dividing by the length (L) from the anterior commissure to the vocal process [normalized mucosal wave amplitude = (d2 -d1)/L × 100(u)]. The glottal gap was examined on the images during Histologic Examination. The collagen, elastin, and HA in the lamina propria of each vocal fold were examined under light microscopy. The thickness of the lamina propria was also assessed to determine the degree of scar contraction. After the excised larynx experiments, the vocal fold tissues were fixed with 10% formaldehyde and then embedded in paraffin. Four-micrometer-thick serial sections were prepared in the coronal plane. The sections were made in the same systematic manner, beginning from the anteroposterior middle portion and proceeding through the anterior and posterior portions of the vocal fold. Elastica-van Gieson staining was performed to identify collagen and elastin separately. The hyaluronidase digestion technique was used to detect HA. For the hyaluronidase digestion procedure, 50 mg of bovine testes hyaluronidase (Sigma, St Louis, Missouri) was diluted in 100 mL PBS, and each section was incubated in this solution for 1 hour at 37°C. Next, the sections were stained with Alcian blue (pH 2.5). Hyaluronic acid was detected by comparing the sections without digestion to those with digestion. Images were captured with an Olympus BX50 microscope (Olympus Corporation, Tokyo, Japan). Collagen and HA were examined at 2× microscopic power, and elastin was examined at 20× microscopic power in the lamina propria. The thickness of the lamina propria was determined by measuring the distance from the free edge of the vocal fold down to the muscle layer at 2× microscopic power with Adobe Photoshop Image Analysis Software (Adobe Systems Inc, San Jose, California). The thickness of the treated lamina propria was represented by the ratio of the pixel size of the treated side to that of the normal side.
Statistical Analysis. Statistical analyses were performed for comparisons of the normalized mucosal wave amplitude, the normalized glottic gap, and the thickness of the lamina propria between the HGFtreated and the sham groups by use of the Mann-Whitney U-test. A p value of less than or equal to .05 was considered statistically significant.
RESULTS
Vibratory Data. Vibratory examinations showed better mucosal vibration in the HGF-treated group than in the sham group. Incomplete glottal closure and volume deficiency of the vocal fold were significant in the sham group (Fig 1A) , whereas a smaller glottal gap and an improved vibratory pattern were observed in the HGF-treated group (Fig 1B) .
The normalized mucosal wave amplitude was significantly greater in the HGF-treated group than in the sham group (p < .05; Fig 2A) . Since the normal range of the normalized mucosal wave amplitude in dogs has been reported to be 6 to 10 units, 11 all normalized mucosal wave amplitude values for the current HGF-treated group were within the normal range, whereas the values in the sham group were shown to be beyond the normal range. Although there was still glottal incompetence in the HGF-treated group, the normalized glottal gap was Fig 2B) .
Histologic Data. Collagen and elastin were located mainly in the superficial layer of the lamina propria, whereas HA was distributed throughout the entire layer in the normal control vocal folds. In the sham group, remarkable tissue contraction and disorganized collagen deposition were noted throughout the scarred lamina propria compared with the normal side ( Fig 3A,B) , and elastin and HA were remarkably decreased on the sham side compared to the normal side ( Fig 3C-F) .
In the HGF-treated group, tissue contraction and collagen deposition were found to be minimal ( Fig  4A,B) , and the restoration of HA was well identified on the HGF-treated side (Fig 4C,D) . Elastin was also restored in the superficial lamina propria (Fig 4E,F) .
The thickness of the lamina propria was nearly normal in the HGF-treated vocal folds, whereas it was significantly (p < .05) thinner in the sham group than in the HGF-treated group (Fig 5) . DISCUSSION Vocal fold scarring remains a therapeutic challenge to date. In the Chevalier Jackson Lecture at the annual meeting of the American Broncho-Esophagological Association in 1995, Hirano 19 stated that problems in vocal fold scar treatment awaited improvements, and that the most promising future direction would be to develop techniques to replace the scarred tissues with normal pliable mucosa, or to innovate techniques to soften scarred tissues with certain therapeutics and/or physical treatments. Many experimental studies have since revealed the histologic and rheological changes in scarred vocal folds. [5] [6] [7] [20] [21] [22] There have been some discrepancies among the findings on the use of extracellular matrix (ECM) in vocal fold scarring, possibly due to differences in the animal species used, the type of injury, and/or the duration of injury. However, these studies suggested that disorganization of ECM components may affect the tissue properties of the vocal fold mucosa. Excessive or disorganized collagen, reduced elastin, increased fibronectin, and decreased decorin have all been frequently noted. The density of HA did not change in most cases, although the total amount of HA decreased. Although the effects of these changes in ECM molecules on the tissue properties of the vocal fold remain unclear, it appears to be useful to restore these histologic changes to the normal state in the treatment of vocal fold scarring. Based on these findings, various therapeutic strategies for the treatment of scarred vocal folds have attempted to use tissue engineering and regenerative medicine. 10, 11, 23, 24 Therapeutic strategies in regenerative medicine include cell therapy, growth factor therapy, and implantation of regenerative materials. Growth factors are one of the most potent regulatory elements that affect cells and tissue remodeling. Recently, growth factor therapy has been thought to be a notable treatment in various fields of regenerative medicine. Hepatocyte growth factor has strong antifibrotic activity that stimulates HA production in mesenchymal cells and dissolves the collagen matrix. Previous studies using animal models have revealed that injection of HGF solution into scarred vocal folds has therapeutic potential. [9] [10] [11] However, incomplete regeneration was also noted, probably due to the insufficient retention time of HGF in vivo. 12 In order to enhance the effects of HGF in vivo in the present study, we employed a DDS developed at Kyoto University that allowed a gradual release of HGF from gelatin hydrogels in a continuous manner. Indeed, this DDS of HGF has been proven to be useful in preventing the progression of heart failure in strokeprone spontaneously hypertensive rats. 12, 14 In this study, excised larynx experiments showed a significant improvement of mucosal vibration in terms of mucosal wave amplitude and glottal closure in the HGF-treated group. The effects on muco- 
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A sal wave amplitude were consistent across the animals, whereas previous studies using HGF solution demonstrated considerable individual variation. 10, 11 Our results suggest that the current HGF DDS may facilitate continuous and retentive release of the active factor to elicit consistent effects in decreasing stiffness of the scarred vocal folds, thus resulting in improvement of the vibratory properties. Hepatocyte growth factor is thought to regulate excessive collagen deposition, prevent tissue contraction, and stimulate HA production. Histologic evaluation of the HGF-treated group in the present study indicated a remarkable reduction of collagen deposition and tissue contraction, with favorable restoration of HA in the lamina propria. The current HGF DDS also restored elastin deposition, whereas elastin was not restored by local injection of HGF solution in previous studies. 10, 11 The current results imply that the effects of HGF on vocal fold regeneration may be improved by the present DDS instead of injection of solution. However, further studies are needed to determine the ideal dose and administration frequency of HGF hydrogels to achieve complete regeneration of scarred vocal folds. It is also important to confirm the actual controlled release of HGF from the hydrogels in the vocal folds in the future, although such release has been clarified in other areas of the body.
CONCLUSIONS
The present study demonstrated that the HGF DDS significantly improved the vibratory properties of scarred vocal folds in a canine model. It reduced excessive collagen deposition and tissue contraction, with favorable restoration of HA and elastin. The results also suggest that the HGF DDS may produce more consistent effects on restoration of scarred vocal folds than does local administration of HGF solution.
